Jiayu Song

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Ligustroflavone alleviates chronic kidney disease by inhibiting ferroptosis through the GSK3β/NRF2 signaling pathway.

Ligustroflavone alleviates chronic kidney disease by inhibiting ferroptosis through the GSK3β/NRF2 signaling pathway.

Journal: Redox report : communications in free radical research

Published: February 25, 2026

Ligustroflavone protects against acute kidney injury by inhibiting ferroptosis via acting on GSK3β/NRF2 signaling.

Ligustroflavone protects against acute kidney injury by inhibiting ferroptosis via acting on GSK3β/NRF2 signaling.

Journal: International journal of molecular medicine

Published: January 09, 2026

Application of the nephrotoxic serum nephritis model in glomerulonephritis research.

Application of the nephrotoxic serum nephritis model in glomerulonephritis research.

Journal: Molecular medicine (Cambridge, Mass.)

Published: October 23, 2025

The intricate role of annexin A2 in kidney: a comprehensive review.

The intricate role of annexin A2 in kidney: a comprehensive review.

Journal: Renal failure

Published: November 13, 2023

Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.

Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 27, 2023

Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis.

Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis.

Journal: Oxidative medicine and cellular longevity

Published: June 16, 2022

Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.

Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.

Journal: Renal failure

Published: March 30, 2022

Mitochondrial quality control in acute kidney disease.

Mitochondrial quality control in acute kidney disease.

Journal: Journal of nephrology

Published: March 26, 2022

Case Report: A Novel Non-Canonical Splice Site Variant (c.1638+7T>C) in TRPM6 Cause Primary Homagnesemia With Secondary Hocalcemia.

Case Report: A Novel Non-Canonical Splice Site Variant (c.1638+7T>C) in TRPM6 Cause Primary Homagnesemia With Secondary Hocalcemia.

Journal: Frontiers in pediatrics

Published: December 13, 2021

Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.

Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.

Journal: Kidney international

Published: March 09, 2020

Estrogen-related receptor-α mediates puromycin aminonucleoside-induced mesangial cell apoptosis and inflammatory injury.

Estrogen-related receptor-α mediates puromycin aminonucleoside-induced mesangial cell apoptosis and inflammatory injury.

Journal: American journal of physiology. Renal physiology

Published: January 31, 2019

Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology.

Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology.

Journal: American journal of translational research

Published: November 14, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026